New advances in the management of lung cancer are now making their appearance in the practice of oncology. Among the innovations are targeted therapies that have various modes of action. Think of them as 'smart bombs', as opposed to the more traditioanal 'sluster bomb'. One such drug is now availbale in Malaysia, reports PAUL YEO.
THE fact is, only about 14% of people who develop lung cancer survive for five years.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
